The real-life experience of vedolizumab therapy in the OBSERV-IBD cohort: a 3-year prospective observational multi-centre cohort study - Université de Picardie Jules Verne
Communication Dans Un Congrès Année : 2019

The real-life experience of vedolizumab therapy in the OBSERV-IBD cohort: a 3-year prospective observational multi-centre cohort study

M. Allez
  • Fonction : Auteur
S. Viennot
  • Fonction : Auteur
A. Aubourg
  • Fonction : Auteur
Y. Bouhnik

Dates et versions

hal-03552293 , version 1 (02-02-2022)

Identifiants

Citer

A. Amiot, M. Serrero, L. Peyrin-Biroulet, J. Filippi, B. Pariente, et al.. The real-life experience of vedolizumab therapy in the OBSERV-IBD cohort: a 3-year prospective observational multi-centre cohort study. 14. Congress of ECCO, European Crohn’s and Colitis Organisation, Mar 2019, Copenhague, Denmark. ⟨10.1093/ecco-jcc/jjy222.835⟩. ⟨hal-03552293⟩
72 Consultations
0 Téléchargements

Altmetric

Partager

More